Search results
Results From The WOW.Com Content Network
Wickham striae or Wickham's striae are whitish lines visible in the papules of lichen planus and other dermatoses, typically in the oral mucosa. [1] The microscopic appearance shows hypergranulosis .
Lichen planus may be categorized as affecting mucosal or cutaneous surfaces.. Cutaneous forms are those affecting the skin, scalp, and nails. [10] [11] [12]Mucosal forms are those affecting the lining of the gastrointestinal tract (mouth, pharynx, esophagus, stomach, anus), larynx, and other mucosal surfaces including the genitals, peritoneum, ears, nose, bladder and conjunctiva of the eyes.
A constant improvement of lesions, a depletion of Wickham striae, and a disappearance of erosions were observed at weeks four and eight of treatment. At week twelve, there was a total recovery of the right buccal mucosa. No adverse events have occurred during the treatment and Abrocitinib was well tolerated by the patient. [28]
Louis Frédéric Wickham (28 February 1861 in Paris – 14 October 1913 in Mesnil-le-Roi) was a French physician and pathologist remembered for describing Wickham striae. [1] He trained in medicine in Paris, receiving his M.D. in 1890.
Desquamative gingivitis is a descriptive clinical term, not a diagnosis. [1] Dermatologic conditions cause about 75% of cases of desquamative gingivitis, and over 95% of the dermatologic cases are accounted for by either oral lichen planus or cicatricial pemphigoid. [1]
Striae are caused by tearing of the dermis during periods of rapid growth of the body, such as during puberty or pregnancy, in which they usually form during the last trimester. Usually on the belly, these striae also commonly occur on the breasts, thighs, hips, lower back, and buttocks. Pregnancy-related striae are known as striae gravidarum. [2]
higher potency corticosteroids, more frequent application, extended duration of treatment, [3] use of occlusion, infancy/childhood, location [2] Diagnostic method: Visual inspection of skin for visible signs of skin atrophy [1] Prevention: Intermittent maintenance therapy; increasing duration of interval between applications [4] Management
This page was last edited on 28 September 2021, at 21:39 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.